GWAS-loci mapping analyses revealed a GWAS-identified bladder cancer risk SNP near those used to predict expression of FAM53A (rs798766 located in TACC3 near FGFR3)4–6. This evidence concerns the gene TACC3 and urinary bladder carcinoma.